About
Injectable Back Pain Treatment
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (12)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
149
By Phase
PHASE1: 2PHASE2: 1
By Status
UNKNOWN: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06022263Lead Sponsor
STA363 in the Treatment of Lumbar Disc Herniation
PHASE1Unknown
24 participants
Started: Jul 25, 2023 · Completed: Aug 31, 2024
NCT04673461Lead Sponsor
Study Investigating STA363 Compared to Placebo in Patients With Chronic Discogenic Low Back Pain
PHASE2Unknown
110 participants
Started: Jul 31, 2020 · Completed: Oct 31, 2023
NCT03055845Lead Sponsor
A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain
PHASE1Completed
15 participants
Started: Mar 27, 2017 · Completed: Aug 29, 2019
Locations (1)
Headquarters
Gothenburg, Sweden
Map
Loading map...